How a 70 Percent Stock-Out Rate Fell to 2 Percent: Rebuilding Zambia's Laboratory Supply Chain

How a 70 Percent Stock-Out Rate Fell to 2 Percent: Rebuilding Zambia's Laboratory Supply Chain

For years, Zambia's laboratory program ran short of the basic supplies that keep patients tested and staff safe. CD4 test kits, viral load reagents, gentian violet stain, gloves, and other personal protective equipment were often missing from the shelf. Without them, laboratories could not support the country's HIV/AIDS, tuberculosis, malaria, and maternal and child health services.

The situation was dire. At baseline, more than 70 percent of essential reagents were out of stock. The few reagents that were available often came in the wrong mix. A single test might require four items, such as a test kit, saline solution, decontamination solution, and a lyophilized reagent, yet a laboratory would have only two of them on hand. The other two sat unused. Equipment told the same story. Analyzers broke down and stayed down because there was no maintenance contract, no service provider, no spare parts, and no control reagents to run them. A laboratory can have skilled staff and modern machines and still fail patients if the supply chain behind it does not work.

A mandate and a first meeting

That began to change in 2007 when the United States President's Emergency Plan for AIDS Relief (PEPFAR), working through the United States Agency for International Development (USAID), brought the Supply Chain Management System (SCMS) project to Zambia. SCMS was implemented by the Partnership for Supply Chain Management (PFSCM), a consortium led by John Snow, Inc. (JSI). I joined as the senior laboratory logistics advisor from April 2007 to July 2012. My charge was to assess the state of laboratory services across the country and design a strategy to fix them.

I started with people, not products. Together with a team of local and international laboratory specialists, I convened a stakeholder sensitization meeting to brief the Ministry of Health and its partners on the project goals and to ask for their input and buy-in on the implementation framework. That early buy-in paid for itself many times over in the two years that followed.

Step one: measure the gap

The first task was a comprehensive stock assessment of the reagents most critical to diagnosing and monitoring HIV/AIDS, tuberculosis, malaria, and maternal and child health conditions. We chose these reagents deliberately. Zambia's HIV prevalence was among the highest in the region and in the world, so any gap in testing supplies translated directly into patients going undiagnosed or untreated.

We randomly selected 90 of the country's 275 facilities, stratified by level of care: health centers, district hospitals, provincial hospitals, and national and teaching hospitals. The finding was stark. Seven of the ten key reagents had been out of stock within the 48 hours before our visit, at every level of the health system. This was the first site-level data anyone had collected on the problem, and it gave the government and its partners something they had not had before: proof. When I presented the report to national stakeholders, I called for immediate action and rapid resource mobilization to procure, deliver, and stock every reagent on the list. Data turned a long-standing complaint into an urgent decision.

Step two: build the system

Procurement alone would not solve the problem. Without a working logistics system, new stock would simply run out again in the wrong places at the wrong times. So the next layer of the strategy was to design standardized logistics and supply chain procedures that would put reagents in front of service providers when they needed them and in the quantities they needed.

We built a set of standardized data collection and reporting tools: stock control cards, consumption and reconciliation forms, report and request forms, and a standard testing menu for each level of care. Together, these gave the country a single framework covering which tests each facility should offer, how facilities would record consumption, stock on hand, losses, and adjustments, and how long each resupply cycle would take. For the first time, a district hospital and a national reference laboratory were speaking the same logistics language.

Step three: test it before scaling it

We piloted the new system in a separate group of 140 facilities, about half of all facilities in the country, for at least three reporting cycles, or six months. The pilot measured compliance, user experience, and how readily staff accepted the new tools. Key performance indicators included the reporting rate per facility, the quality of the reported data, stock on hand, and losses and expiries. At the end of the pilot, I led the evaluation, wrote the report and recommendations, and ran the dissemination workshop where stakeholders reviewed the findings. Several design adjustments came directly out of that workshop.

Step four: train the trainers, then let them lead

With the pilot complete and the design refined, I led a national training-of-trainers workshop for national and regional trainers. Those trainers then cascaded the training through regions, provinces, and districts to every health facility in the country. The rollout continued until at least two people in each facility were trained to operate the system.

Two years into full operation, we repeated the evaluation using the same ten key reagents from the baseline assessment. This time, only zero point two of the ten had been out of stock in the 48 hours before the visit. Seven percent had become two percent.

What I took away

The success of the project became a benchmark for laboratory logistics design in other PEPFAR countries, and the lessons have stayed with me:

1. Early stakeholder involvement, input, and buy-in are essential. The people who will run a system must help shape it.

2. Baseline data builds trust and creates urgency. Nobody argued with the numbers.

3. A pilot phase surfaces bottlenecks in user acceptance, training gaps, and priorities before they become national problems.

4. Training of trainers works. Local personnel cascading training to their peers outperforms parachuting in international experts.

5. Sustained collaboration with the national laboratory authority, including their commitment to and participation in workshops, meetings, and stakeholder sessions, is critical to program success.

The honest footnote

None of this was easy. Financial commitment from the government was limited. Procurement lead times were long. Many laboratory reagents have short shelf lives and require cold chain handling during storage and transport. And some staff resisted new tools, forms, and reports simply because they were new. Those challenges never disappeared. What changed was that the system could now see them coming and respond.